Aspirin Mouthwash in Treating Patients With Oral Leukoplakia
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Aspirin mouthwash may stop the growth of tumor cells by blocking some of the
enzymes needed for cell growth.
PURPOSE: This phase I trial is studying the side effects and best dose of aspirin mouthwash
in treating patients with oral leukoplakia.
Phase:
Phase 1
Details
Lead Sponsor:
Institute of Head and Neck Studies and Education, United Kingdom